Evaluating STAT5 Phosphorylation as a Mean to Assess T Cell Proliferation

Front Immunol. 2019 Apr 5:10:722. doi: 10.3389/fimmu.2019.00722. eCollection 2019.

Abstract

Here we present a simple and sensitive flow cytometric-based assay to assess T cell proliferation. Given the critical role STAT5A phosphorylation in T cell proliferation, we decided to evaluate phosphorylation of STAT5A as an indicator of T cell proliferation. We determined pSTAT5A in T cell treated with either CD3/CD28 or PHA. After stimulation, T cells from adult healthy donors displayed a strong long-lasting phosphorylation of STAT5A, reaching a peak value after 24 h. The median fluorescence intensity (MFI) of pSTAT5A increased from 112 ± 17 to 512 ± 278 (CD3/CD28) (24 h) and to 413 ± 123 (PHA) (24 h), the IL-2 receptor-α (CD25) expression was greatly enhanced and after 72 h T cell proliferation amounted to 52.3 ± 10.3% (CD3/CD28) and to 48.4 ± 9.7% (PHA). Treatment with specific JAK3 and STAT5 inhibitors resulted in a complete blockage of phosphorylation of STAT5A, CD25 expression, and suppression of T cell proliferation. Compared with currently available methods, STAT5A phosphorylation is well-suited to predict T cell proliferation. Moreover, the method presented here is not very time consuming (several hours) and delivers functional information from which conclusions about T cell proliferation can be drawn.

Keywords: CD25; STAT5 activation; T cell activation; T cell proliferation; flow cytometry.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cell Proliferation
  • Cells, Cultured
  • Female
  • Flow Cytometry
  • Healthy Volunteers
  • Humans
  • Immunoassay / methods*
  • Janus Kinase 3 / metabolism
  • Lymphocyte Activation
  • Male
  • Phosphorylation / immunology*
  • STAT5 Transcription Factor / metabolism*
  • Signal Transduction
  • T-Lymphocytes / immunology

Substances

  • STAT5 Transcription Factor
  • Janus Kinase 3